Roger Hajjar

Roger Hajjar

Company: Sardocor Corp

Job title: President


Elucidating Novel AAV/SERCA2a Gene Therapy for the Treatment of Duchenne Cardiomyopathy 9:30 am

Cardiomyopathy associated with Duchenne continues to cause morbidity and mortality in affected patients Directed gene therapy to treat cardiomyopathy has not been available yet Delivery of AAV/SERCA2a in patients with cardiomyopathy is a promising strategy for improving the lives of patients in needRead more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.